Vanda Pharmaceuticals Inc
NASDAQ:VNDA
Income Statement
Earnings Waterfall
Vanda Pharmaceuticals Inc
Revenue
|
192.6m
USD
|
Cost of Revenue
|
-14.8m
USD
|
Gross Profit
|
177.8m
USD
|
Operating Expenses
|
-191.8m
USD
|
Operating Income
|
-14m
USD
|
Other Expenses
|
16.5m
USD
|
Net Income
|
2.5m
USD
|
Income Statement
Vanda Pharmaceuticals Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
34
N/A
|
35
+3%
|
37
+7%
|
44
+16%
|
50
+15%
|
63
+26%
|
80
+26%
|
93
+17%
|
110
+18%
|
121
+10%
|
129
+7%
|
140
+8%
|
146
+5%
|
150
+3%
|
156
+4%
|
159
+2%
|
165
+4%
|
171
+4%
|
177
+3%
|
184
+4%
|
193
+5%
|
197
+2%
|
209
+6%
|
219
+5%
|
227
+4%
|
237
+5%
|
241
+1%
|
241
+0%
|
248
+3%
|
253
+2%
|
259
+2%
|
268
+4%
|
269
+0%
|
266
-1%
|
263
-1%
|
258
-2%
|
254
-1%
|
257
+1%
|
238
-7%
|
212
-11%
|
193
-9%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
(0)
|
(1)
|
(2)
|
(7)
|
(12)
|
(18)
|
(24)
|
(24)
|
(25)
|
(26)
|
(25)
|
(23)
|
(21)
|
(18)
|
(18)
|
(18)
|
(19)
|
(20)
|
(21)
|
(21)
|
(22)
|
(24)
|
(25)
|
(25)
|
(24)
|
(23)
|
(23)
|
(24)
|
(25)
|
(26)
|
(26)
|
(25)
|
(25)
|
(24)
|
(24)
|
(23)
|
(21)
|
(18)
|
(15)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
11
N/A
|
25
+132%
|
49
+96%
|
57
+16%
|
68
+20%
|
75
+11%
|
87
+15%
|
97
+12%
|
104
+8%
|
114
+9%
|
121
+6%
|
127
+5%
|
135
+6%
|
141
+4%
|
147
+5%
|
153
+4%
|
157
+3%
|
165
+5%
|
173
+5%
|
176
+2%
|
187
+6%
|
195
+5%
|
203
+4%
|
213
+5%
|
217
+2%
|
218
+1%
|
225
+3%
|
229
+2%
|
234
+2%
|
243
+4%
|
243
+0%
|
241
-1%
|
238
-1%
|
234
-2%
|
230
-2%
|
233
+1%
|
218
-7%
|
194
-11%
|
178
-8%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(55)
|
(78)
|
(99)
|
(100)
|
(106)
|
(20)
|
(15)
|
(31)
|
(127)
|
(139)
|
(146)
|
(147)
|
(140)
|
(141)
|
(147)
|
(156)
|
(164)
|
(159)
|
(158)
|
(154)
|
(151)
|
(159)
|
(164)
|
(168)
|
(180)
|
(188)
|
(191)
|
(194)
|
(191)
|
(191)
|
(193)
|
(199)
|
(181)
|
(217)
|
(223)
|
(225)
|
(224)
|
(217)
|
(208)
|
(195)
|
(192)
|
|
Selling, General & Administrative |
(25)
|
(49)
|
(72)
|
(77)
|
(85)
|
(76)
|
(66)
|
(73)
|
(85)
|
(95)
|
(101)
|
(105)
|
(100)
|
(101)
|
(107)
|
(117)
|
(124)
|
(120)
|
(117)
|
(112)
|
(106)
|
(110)
|
(113)
|
(118)
|
(130)
|
(136)
|
(138)
|
(142)
|
(141)
|
(133)
|
(128)
|
(126)
|
(124)
|
(135)
|
(140)
|
(137)
|
(137)
|
(132)
|
(127)
|
(122)
|
(113)
|
|
Research & Development |
(29)
|
(28)
|
(25)
|
(21)
|
(19)
|
(16)
|
(19)
|
(25)
|
(29)
|
(32)
|
(33)
|
(30)
|
(29)
|
(32)
|
(33)
|
(36)
|
(39)
|
(37)
|
(40)
|
(41)
|
(44)
|
(47)
|
(49)
|
(49)
|
(49)
|
(51)
|
(51)
|
(51)
|
(49)
|
(51)
|
(61)
|
(69)
|
(56)
|
(62)
|
(63)
|
(68)
|
(86)
|
(84)
|
(79)
|
(71)
|
(77)
|
|
Depreciation & Amortization |
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(6)
|
(8)
|
(11)
|
(13)
|
(12)
|
(12)
|
(12)
|
(11)
|
(8)
|
(6)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
78
|
78
|
78
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
(3)
|
0
|
0
|
(18)
|
(18)
|
(18)
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(21)
N/A
|
(43)
-104%
|
(61)
-42%
|
(57)
+6%
|
(58)
0%
|
36
N/A
|
52
+44%
|
44
-15%
|
(40)
N/A
|
(42)
-5%
|
(42)
+2%
|
(33)
+21%
|
(19)
+43%
|
(14)
+25%
|
(11)
+21%
|
(15)
-38%
|
(17)
-10%
|
(7)
+61%
|
(1)
+89%
|
10
N/A
|
22
+108%
|
17
-21%
|
23
+35%
|
28
+20%
|
23
-18%
|
25
+9%
|
26
+5%
|
24
-8%
|
34
+42%
|
38
+11%
|
41
+8%
|
44
+8%
|
62
+41%
|
24
-61%
|
15
-37%
|
8
-45%
|
6
-24%
|
16
+154%
|
10
-40%
|
(0)
N/A
|
(14)
-5 713%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Non-Reccuring Items |
0
|
0
|
0
|
0
|
78
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(3)
|
(7)
|
0
|
0
|
0
|
(20)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
4
|
4
|
5
|
6
|
6
|
6
|
6
|
6
|
4
|
3
|
1
|
1
|
0
|
0
|
0
|
2
|
5
|
8
|
14
|
18
|
20
|
|
Pre-Tax Income |
(21)
N/A
|
(43)
-105%
|
(61)
-42%
|
(57)
+6%
|
20
N/A
|
36
+81%
|
53
+44%
|
45
-15%
|
(40)
N/A
|
(42)
-5%
|
(41)
+2%
|
(32)
+22%
|
(18)
+44%
|
(13)
+26%
|
(10)
+23%
|
(14)
-41%
|
(15)
-9%
|
(5)
+69%
|
1
N/A
|
13
+797%
|
25
+91%
|
22
-14%
|
29
+32%
|
34
+18%
|
29
-14%
|
31
+6%
|
30
-1%
|
27
-13%
|
32
+19%
|
41
+29%
|
42
+4%
|
45
+5%
|
42
-5%
|
24
-43%
|
16
-36%
|
10
-34%
|
11
+10%
|
24
+116%
|
23
-5%
|
18
-24%
|
6
-64%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
88
|
87
|
86
|
83
|
(7)
|
(8)
|
(9)
|
(10)
|
(10)
|
(9)
|
(6)
|
(5)
|
(4)
|
(5)
|
(8)
|
(8)
|
(6)
|
(4)
|
|
Income from Continuing Operations |
(21)
|
(43)
|
(61)
|
(57)
|
20
|
36
|
53
|
45
|
(40)
|
(42)
|
(41)
|
(32)
|
(18)
|
(13)
|
(10)
|
(14)
|
(16)
|
(5)
|
1
|
13
|
25
|
22
|
28
|
122
|
116
|
117
|
114
|
19
|
23
|
32
|
32
|
34
|
33
|
18
|
11
|
6
|
6
|
16
|
15
|
12
|
3
|
|
Net Income (Common) |
(21)
N/A
|
(43)
-105%
|
(61)
-42%
|
(57)
+6%
|
20
N/A
|
36
+81%
|
53
+44%
|
45
-15%
|
(40)
N/A
|
(42)
-5%
|
(41)
+2%
|
(32)
+22%
|
(18)
+44%
|
(13)
+26%
|
(10)
+23%
|
(14)
-40%
|
(16)
-9%
|
(5)
+69%
|
1
N/A
|
13
+909%
|
25
+94%
|
22
-15%
|
28
+32%
|
122
+328%
|
116
-5%
|
117
+1%
|
114
-2%
|
19
-83%
|
23
+20%
|
32
+35%
|
32
+3%
|
34
+6%
|
33
-3%
|
18
-46%
|
11
-39%
|
6
-41%
|
6
-3%
|
16
+153%
|
15
-7%
|
12
-21%
|
3
-79%
|
|
EPS (Diluted) |
-0.63
N/A
|
-1.27
-102%
|
-1.8
-42%
|
-1.7
+6%
|
0.55
N/A
|
0.87
+58%
|
1.25
+44%
|
1.05
-16%
|
-0.94
N/A
|
-0.99
-5%
|
-0.97
+2%
|
-0.76
+22%
|
-0.41
+46%
|
-0.3
+27%
|
-0.22
+27%
|
-0.31
-41%
|
-0.35
-13%
|
-0.11
+69%
|
0.01
N/A
|
0.24
+2 300%
|
0.48
+100%
|
0.4
-17%
|
0.52
+30%
|
2.23
+329%
|
2.11
-5%
|
2.14
+1%
|
2.06
-4%
|
0.36
-83%
|
0.42
+17%
|
0.57
+36%
|
0.58
+2%
|
0.61
+5%
|
0.58
-5%
|
0.32
-45%
|
0.2
-38%
|
0.12
-40%
|
0.11
-8%
|
0.29
+164%
|
0.27
-7%
|
0.21
-22%
|
0.04
-81%
|